Open Access Publisher and Free Library
13-punishment.jpg

PUNISHMENT

PUNISHMENT-PRISON-HISTORY-CORPORAL-PUNISHMENT-PAROLE-ALTERNATIVES. MORE in the Toch Library Collection

The crisis of overcrowded prisons in Indonesia: Barriers to accessing alternatives to imprisonment

By Nixon Randy Sinaga

Indonesia maintains a punitive war on drugs policy model. Various campaigns are conducted to emphasise that drug offences are the most serious crimes. This construction is clearly contrary to international human rights standards. The Human Rights Committee defines the meaning of ‘most serious crime’ through General Comment No. 36 (2018) on Article 6 of the International Covenant on Civil and Political Rights, on the right to life (GC/36). Paragraph 35 of GC/36 does not place drug offences as one of the most serious crimes. This further confirms that Indonesia’s war on drugs policy has been built upon an erroneous and unfounded paradigm. Law Number 35 of 2009 concerning Narcotics (Narcotics Law) which is in force until now contains offences that tend to open up extensive interpretations and overlap between one another. The implication of this overlapping offence in the Narcotics Law is the imprisonment of people who use drugs, people who have drug dependency, and people who abuse drugs. The paradigm of the most serious crime built by the government in narcotics cases actually brings problems to the conditions of correctional institutions in Indonesia. The problem is at least evident from the results of an assessment of the characteristics of people incarcerated for drug cases conducted by the Jakarta Regional Office of the Ministry of Law and Human Rights, stating that at the end of 2018, the number of people in prison for drug cases reached 115,289 people or 95% of the total number of people imprisoned for special criminal cases in Indonesia. This figure is much higher than the number of people detained in corruption cases (5,110), illegal logging (890), terrorism (441), and money laundering (165).

London: International Drug Policy Consortium, 2024. 8p.